ACUTAAS.NS Earnings — Acutaas Chemicals Limited
NSE
Updated
When is ACUTAAS.NS's next earnings date?
Acutaas Chemicals Limited (ACUTAAS.NS) has not announced its next earnings date yet. Its most recent earnings report was on Wednesday, October 28, 2026.
How did ACUTAAS.NS do in its last earnings report?
In its most recent report on Oct 28, 2026, Acutaas Chemicals Limited posted EPS of $15.24 versus the $14.15 estimate, a beat of 7.7%. Revenue was $4.37B against a $4.03B estimate.
How much does ACUTAAS.NS stock move after earnings?
ACUTAAS.NS beat EPS estimates in 2 of its last 3 reported quarters.
About Acutaas Chemicals Limited
Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceutical ingredients (APIs) for a wide range of medical treatments, including those for anti-retroviral applications, inflammation, psychiatric conditions, cancer, Parkinson's disease, depression, and blood coagulation disorders. The company also produces a diverse portfolio of specialty chemicals, serving various industries such as battery manufacturing, personal care, agricultural chemicals, protective coatings, electronics, and general industrial processes. Notable offerings in this category include photoresist chemicals for semiconductor fabrication and electrolyte additives essential for lithium battery cells. Additionally, Acutaas Chemicals provides commodity chemicals like parabens and methyl salicylate, among other fine chemicals, which find application in cosmetics, agricultural products, and various chemical sectors. The company was previously known as Ami Organics Limited, changing its name to Acutaas Chemicals Limited in May 2025.
🤖 AI Earnings Analysis
Acutaas beat estimates on both EPS ($15.24 vs. $14.15) and revenue ($4.4B vs. $4.0B), a strong result; however, extreme growth rates look distorted, and no catalyst or guidance supports extrapolation.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-28 | 14.15 | 15.24 | +7.70% | $4.37B | ✅ Beat | — | — | — | |
| 2026-10-27 | 11.05 | 15.10 | — | $4.33B | ✅ Beat | — | — | — | |
| 2026-07-24 | 9.35 | 9.10 | — | $3.35B | ❌ Miss | — | — | — |
Showing last 3 quarters.